Methicillin-resistant staphylococcus aureus colonization: A review of the literature on prevention and eradication

Advanced Emergency Nursing Journal

Volumn 30, Issue 4, 2008, Pages 344-356

  Ro, Kumhee ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Chlorhexidine; Decolonization; Eradication; MRSA; Mupirocin

Indexed keywords

EID: 67649974126     PISSN: 19314485     EISSN: None     Source Type: Journal    
DOI: 10.1097/TME.0b013e31818bcf45     Document Type: Article

References (30)

1. Bertino S. (1997). Intranasal mupirocin for outbreaks of methicillin-resistant Staphylococcus aureus. American Journal of Health-System Pharmacy, 54, 2185-2191.
2. Boyce M. (1989). Methicillin-resistant Staphylococcus aureus. Detection, epidemiology and control measure. Infectious Disease Clinics of North America, 3, 901-913.
3. Centers for Disease Control and Prevention. (2006). Management of multidrug-resistant organisms in healthcare settings. Siegel, J. D., Rhinehart,Jackson, M., Chiarello, & the Healthcare Infection Control Practice Advisory Committee. Retrieved from http://www.cdc.gov/ncidod/dhqp/pdf/ ar/mdroGUidelin2006.pdf
4. Conly, J., & Johnston L. (2000). Antibiotic resistance in Canada at the dawn of the new millennium-a model for the developed world? Canadian Journal of Infectious Diseases, 11, 232-235.
5. Diep, B. A., Chambers, H. F., Graber H., Szmowski, J. D., Miller, L. G., Han L., et al. (2008). Emergence of multidrug resistant community associated methicillin resistant Staphylococcus aureus clone USA 300 in men who have sex with men. Annals of Internal Medicine, 148(4), 249-257.
6. Dupeyron, C., Campillo, B., Bordes, M., Faubert, Richardety, J. P., & Mangeney (2002). A clinical trial of mupirocin in the eradication of methicillin-resistant Staphylococcus aureus nasal carriage in a digestive disease unit. Journal of Hospital Infection, 52(4), 281-287.
7. Dupeyron, C., Campillo, B., Richardet, J. P., & Soussy (2006). Long-term efficacy of mupirocin in the prevention of infections with methicillin-resistant Staphylococcus aureus in gastroenterology unit. Journal of Hospital Infection, 63(4), 385-392.
8. Ellis, M. W., Griffith, M. E., Dooley, D. P., McLean C., Jorgensen, J. H., Patterson E., et al. (2007). Targeted intranasal mupirocin to prevent colonization and infection by community acquired methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial. Antimicrobial Agents and Chemotherapy, 51(10), 3591-3598.
9. Gardam A. (2000). Is methicillin-resistant Staphylococcus aureus an emerging community pathogen? A review of the literature. Canadian Journal of Infectious Diseases, 11(4), 202-211.
10. Gorak, E. J., Yamada, S. M., & Brown D. (1999). Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors. Clinical Infectious Diseases, 29, 797-800.
11. Gorwitz J. (2008). A review of community associated methicillin-reistant Staphylococcus aureus skin and soft tissue infections. Pediatric Infectious Diseases Journal, 27, 1-7.
12. Hanoudi, A. C., Palmer, R. N., & King L. (1983). Nafcillin resistant Staphylococcus aureus: A possible community origin. Infection Control, 4, 153-157.
13. Harbarth, S., Dharan, S., Lisassine, N., Herrault, Auckenthaler, R., & Didier (1999). Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradication carriage of methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy, 43(6), 1412-1416.
14. Jevons P. (1961). Celbenin-resistant Staphylococci. British Medical Journal, 1, 124-125.
15. Kampf, G., & Kramer (2004). Eradication of methicillin-resistant Staphylococcus aureus with an antiseptic soap and nasal mupirocin among colonized patients-an open uncontrolled clinical trial. Annual Clinical Microbiology and Antimicrobiology, 3, 3-9.
16. Kuehnert, M. J., Kruszon-Moran, D., Hill A., McQuillan, G., McAllister, S. K., & Fosheim (2006). Prevalence of Staphylococcus aureus nasal colonization in the United States. Journal of Infectious Diseases, 193, 172-179.
17. Loeb, M., Main, C., Walker-Dilks, C., & Eady (2003). Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database of Systematic Reviews, 4, CD003340.
18. Muller, A., Talon, D., Potier, A., Belle, E., Cappelier, & Bertrand (2005). Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units. Critical Care, 9(3), R246-R250.
19. National Nosocomial Infections Surveillance System. (2004). National Nosocomial Infections Surveillance System Report. American Journal of Infection Control, 32, 470-485.
20. Rathore, M. H., & Kline W. (1989). Communityacquired methicillin-resistant Staphylococcus aureusinfections in children. Pediatric Infectious Disease Journal, 8, 645-647.
21. Ridenour, G., Lampen, R., Federspiel, J., Kritchevsky, Wong, E., & Climo (2007). Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients. Infection Control and Hospital Epidemiology, 28(10), 1155-1161.
22. Rohr, U., Mueller, C., Wilhelm, M., Muhr, & Gatermann (2003). Methicillin-resistant Staphylococcus aureus whole-body decolonization among hospitalized patients with variable site colonization by using mupirocin in combination with octenidine dihydrochloride. Journal of Hospital Infection, 54, 305-309.
23. Said-Salim, B., Mathema, B., & Kreishirth M. (2003). Community-acquired methicillin resistant Staphylococcus aureus: An emerging pathogen. Infection Control and Hospital Epidemiology, 24(6), 451-455.
24. Salgado, C. D., Farr, B. M., & Calfee P. (2003). Community-associated MRSA: A meta-analysis of prevalence and risk factors. Clinical Infectious Diseases, 36, 131-139.
25. Sandri, A. M., Dalarosa, M. G., Ruschel de Alcantara, da Silva Elias, L., & Zavascki P. (2006). Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus infection in an intensive care unit: Role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA. Infection Control and Hospital Epidemiology, 27(2), 185-187.
26. Suzuki, Y., Kamigaki, T., Fujino, Y., Tominaga, M., Ku, & Kuroda (2003). Randomized clinical trial of preoperative intranasal mupirocin to reduce surgical site infection after digestive surgery. British Journal of Surgery, 90, 1072-1075.
27. Thompson, R. L., Cabezudo, I., & Wenzel P. (1982). Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Annals of Internal Medicine, 97, 309-317.
28. Weese, J. S., Dick, H., Willey, B. M., McGeer, Kreiswirth, B. N., Innis, et al. (2006). Suspected transmission of methicillin-resistant Staphylococcus aureus between domestic pets and humans in veterinary clinic and in the household. Veterinary Microbiology, 115, 148-155.
29. Wendt, C., Schinke, S., WurHemberger, Oberdorfer, K., Bock-Hensley, O., & von Baum (2007). Value of whole-body washing with chlorhexidine for the eradication of MRSA: A randomized, placebo-controlled, double-blind clinical trial. Infection Control and Hospital Epidemiology, 28(9), 1036-1043.
30. Wilcox, M. H., Hall, J., Pike, H., Templeton A., Fawley, W. N., Parnell, et al. (2003). Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus orthopedic surgical site infections. Journal of Hospital Infection, 54(3), 196-201.